OPTIMAL CRE: Introduction to MG Webinar

The Introduction to Myasthenia Gravis Webinar held on November 24th 2025 features various Australian-based MGBase investigators and valuable partners who are members of the OPTIMAL CRE Myasthenia Gravis Working Group. 

In this interactive webinar, the OPTIMAL NHMRC Centre of Research Excellence, in partnership with Myasthenia Alliance Australia, brings together patients, clinicians, and researchers to discuss current and future approaches to immunoglobulin therapy in Myasthenia Gravis. 

The session covers an overview of the condition, lived-experience insights and updates from a national research study focused on optimising intravenous immunoglobulin (IVIg) use. The webinar also highlights how patient preferences can inform future models of care, followed by a panel discussion and live Q&A.